genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2023

Cardiology

Why Recombinants Are Essential for Assay Development and Production
Insights

Why Recombinants Are Essential for Assay Development and Production

Unconscious Wakefulness Linked to Increased Risk of Death from CVD and Any Cause, Particularly among Women
News

Unconscious Wakefulness Linked to Increased Risk of Death from CVD and Any Cause, Particularly among Women

Bayer to Acquire BlueRock Therapeutics for Up-to-$600M, with Cell Therapy Pipeline in Mind
Drug Discovery

Bayer to Acquire BlueRock Therapeutics for Up-to-$600M, with Cell Therapy Pipeline in Mind

Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine
Insights

Why Cardiology Is Ripe to Become the Next Frontier for Precision Medicine

X-Chem, Astellas Launch Drug Discovery Collaboration
Drug Discovery

X-Chem, Astellas Launch Drug Discovery Collaboration

Hitachi Chemical Agrees $75M Deal for Caladrius Cell Therapy Manufacturer, PCT
Drug Discovery

Hitachi Chemical Agrees $75M Deal for Caladrius Cell Therapy Manufacturer, PCT

Bayer to Use T2 Biosystems’ T2MR Platform in Hemostasis Collaboration
Industry News

Bayer to Use T2 Biosystems’ T2MR Platform in Hemostasis Collaboration

Caution: Falling Price Zone
Insights

Caution: Falling Price Zone

Tackling Mental Illnesses with a Novel Approach
News

Tackling Mental Illnesses with a Novel Approach

Kyoto University Becomes Bayer’s Latest Drug Discovery Partner
News

Kyoto University Becomes Bayer’s Latest Drug Discovery Partner

12Page 1 of 2

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up